跳至主要内容
临床试验/NCT06674837
NCT06674837尚未招募不适用

Diagnostics and Surveillance of Acute Meningo-encephalitis Among Children in Cambodia With a Focus on Japanese Encephalitis Virus

ANRS, Emerging Infectious Diseases0 个研究点目标入组 4,000 人开始时间: 2025年10月15日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
4,000
主要终点
To quantify Japanese Encephalitis Virus seroconversion in a cohort of asymptomatic children aged 2-14 years

研究概览

简要总结

The primary objective of this study is to quantify the clinical burden of Japanese Encephalitis (JE) and the asymptomatic circulation of JEV among Cambodian children, through two pediatric cohorts: non-febrile children at recruitment and children hospitalized with febrile neurological syndrome (FNS). Secondary objectives include estimating anti-JEV seropositivity rates, identifying individual risk factors and living conditions associated with JEV infection, characterizing clinical and biological profiles related to disease severity, and evaluating the role of deficiencies in interferon (IFN) response in severe JEV infections.

详细描述

This is an observational prospective study (with cross-sectional and longitudinal designs) involving two pediatric cohorts recruited from Kantha Bopha hospitals in Phnom Penh and Siem Reap. Group 1 will consist of 2000 non-febrile children aged 2-14 years, recruited from trauma units and followed up for two years to monitor JEV seroconversion. Group 2 will include 2000 children hospitalized with FNS, confirmed JE participants will be followed up for one year to assess the severity of JEV infection. Diagnostic tools such as the QIAstat molecular diagnostic platform and ELISA will be used to detect multiple pathogens, including JEV and dengue virus (DENV). Data collection will involve clinical assessments, etiological testing, and environmental surveys. All collected information will be integrated into a centralized database for analysis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
2 Years 至 14 Years(Child)
性别
All
接受健康志愿者

入选标准

  • All children aged between 2 and 14 years.
  • No fever or history of fever in the past 14 days.
  • Consenting to return to the hospital for follow-up visits.
  • Consenting to blood sampling.
  • Written informed assent/consent to participate in the study.
  • Hospitalized patients aged between 2 and 14 years.
  • Any neurological disorder.
  • Any fever within the past 72 hours.
  • Written informed assent/consent to participate in the study.
  • No contraindication for lumbar puncture (LP).

排除标准

  • 未提供

结局指标

主要结局

To quantify Japanese Encephalitis Virus seroconversion in a cohort of asymptomatic children aged 2-14 years

时间窗: 24 months

Japanese Encephalitis Virus seroconversion will be determined based on PCR positivity or ELISA results, with confirmatory testing by virus neutralization assays. Unit of Measure: Binary measure (presence or absence) of JEV antibodies or presence of JEV RNA

次要结局

  • To assess factors related to the clinical severity of JEV infection among children hospitalized with febrile neurological symptoms (FNS) who are confirmed JEV cases.(12 months)

研究者

申办方类型
Other Gov
责任方
Sponsor

相似试验